GastroEsophageal Cancer Clinical Trials
4 recruiting trials for GastroEsophageal Cancer. Eligibility criteria explained in plain English.
4
Total Trials
4
Recruiting Now
0
Phase 3 Trials
4
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.
Sponsor: ModeX Therapeutics, An OPKO Health CompanyEnrolling: 1156 locations
RECRUITINGPhase 2NCT06468280
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in...
ROSETTE trial is an open-label, randomized phase II study designed to investigate treatment strategies for patients with limited metastatic gastric or gastroesophageal...
Sponsor: Shanghai Zhongshan HospitalEnrolling: 842 locations
RECRUITINGNCT05205343
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal...
To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.
Sponsor: M.D. Anderson Cancer CenterEnrolling: 204 locations
RECRUITINGPhase 2NCT04069273
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Cohort 1 \[CLOSED\] Study treatment involves two segments: (1) Induction Immunotherapy segment with pembrolizumab monotherapy every 3 weeks until irRECIST PD and (2) Combination...
Sponsor: Harry H YoonEnrolling: 582 locations